According to our latest research, the global Neuralgia Treatment market size reached USD 3.42 billion in 2024. The market is experiencing robust growth with a recorded CAGR of 7.1% from 2025 to 2033, driven by the increasing prevalence of neuralgic disorders and the growing demand for advanced therapeutic options. By 2033, the market is forecasted to reach USD 6.36 billion, reflecting the significant advancements in both pharmacological and non-pharmacological treatment modalities. The market's expansion is primarily attributed to rising awareness, technological innovations in pain management, and an aging global population susceptible to neuralgic conditions. https://growthmarketreports.com/report/neuralgia-treatment-market-global-industry-analysis